Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

The incidence of cardiac AEs was 35% (123 patients) in the PolyHeme group and 29% (105 patients) in the control group (pgreater than0.05). The incidence of cardiac SAEs was 7% (23 patients) in the PolyHeme group and 4% (16 patients) in control (pgreater than0.05). The overall incidence of MI in the study as reported by investigators was 2%: eleven PolyHeme patients and three control patients (p(less than or =)0.05). Three PolyHeme patients and one control patient died.

The medical literature documents the difficulty of making an accurate diagnosis of MI in trauma patients for multiple reasons, including direct trauma to the chest. Myocardial infarction and myocardial ischemia are traditionally assessed by EKGs and the cardiac enzymes Troponin I and CK-MB, both of which can be altered by direct trauma. Approximately 75% of the patients in this study had abnormal EKGs or elevated cardiac enzymes. Because of the disparity between the low number of reported MIs and the high incidence of abnormal EKGs and elevated cardiac enzymes, Northfield has established an independent panel of cardiac experts to review the cardiac profiles of all 720 randomized patients in a blinded fashion to categorize MIs in the study.

Summary

"This was a seminal study. This summary represents our initial opportunity to explore the data on safety and efficacy in detail. We continue to believe there is a potential benefit to using PolyHeme in patients with delayed access to blood, whose expected mortality without oxygen-carrying replacement would be considerably greater," said Dr. Gould.

As the data have not been submitted to FDA, Northfield is preparing a detailed summary of the study data for submission to FDA for review.

About the Study

This randomized, controlled open-label, multi-center, active control pivotal Phase III study of 720 patients was designed to evaluate the safety and efficacy of PolyHeme when used to treat patients in hemorrhagic shoc
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:12/22/2014)... 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a critical ... purification technology to help fight deadly inflammation in ... worldwide, today announced the appointment of Dr. ... its Senior Vice President of Clinical Development, effective ... Di Russo is an accomplished pediatric cardiothoracic ...
(Date:12/22/2014)... Apnea Sciences ( www.apneasciences.com ) announced it ... Aliso Viejo , California.  Jimmy Fallon , ... and worldwide expansion, a new facility with expanded infrastructure ... snore cure have exceeded our expectations and thus required ... in 23 countries and will be increasing to 39 ...
(Date:12/22/2014)... --  TRU-D SmartUVC LLC, producers of the first ... that the General Services Administration has awarded the company ... This newly formed agreement will allow TRU-D SmartUVC ... including Department of Veteran Affairs and Department of Defense ... solutions for the Ebola effort in West ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... REDWOOD CITY, Calif. , June 28 Codexis, ... has joined the company as Senior Vice President, Commercial Operations, ... product management and manufacturing operations worldwide.  He will report to ... and Enzyme Products.   , ...
... , June 28 Graymark Healthcare Inc. (Nasdaq: GRMH ... innovator in comprehensive care for obstructive sleep apnea today announced that it ... over 750 patients. In addition they served over 1275 patients through their ... , Graymark ...
Cached Medicine Technology:Codexis Names Peter Strumph SVP, Commercial Operations 2Graymark Healthcare Sells Record Number of CPAP Devices in Q2 2010 2Graymark Healthcare Sells Record Number of CPAP Devices in Q2 2010 3
(Date:12/26/2014)... “Many people become overwhelmed by the thought of ... phone calls with insurance companies,” The Jones Firm explains ... free eBook on pedestrian and bicycle accidents . ... auto accident claims assures the injured individual that a ... their case while they focus on recovering. , ...
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a ... producing and marketing of a series of induction heating ... new series of induction brazing equipments . , ... induction brazing refers to the joining of two ... heat. The manager says that there are fundamental differences ...
(Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
(Date:12/25/2014)... December 26, 2014 The report “TS-1 ... focuses on the current treatment landscape, unmet needs, current ... TS-1 is an anti-cancer drug which is typically used ... is also used for treating gastric cancer and pancreatic ... potassium. The drug was first approved in 1999 in ...
(Date:12/25/2014)... 2014 Recently, iFitDress.com, the popular online supplier ... announced its new selection of black one-shoulder cocktail dresses ... now; they are available at discounted prices, up to 70% ... will last for three weeks only. You know, we have ... are interested in our new items can visit our website ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... ... based on clinical performance according to Thomson Reuters, a leading provider of information and solutions ... ... Care has been named one of the nation,s top 10 health systems based on ...
... its natural antioxidants protect the skin , FRIDAY, Aug. 14 ... the risk of treatment-linked skin toxicity by two-thirds in ... , Skin reactions are a common side effect of cancer ... they can be expensive and often have their own side ...
... , , WASHINGTON, Aug. 14 ... injunction against the enforcement of an Ohio law strictly regulating the ... Dr. Charmaine Yoest, CEO and President of Americans United for ... Parenthood and other abortion providers have readily admitted that they administer ...
... were at risk for psychosocial problems , FRIDAY, Aug. ... deployed U.S. Army soldiers are at high risk for ... experienced by the parent who is still at home, ... spouses (mainly wives) of 101 deployed Army personnel. Participants ...
... , , MINNEAPOLIS, Aug. 14 ... is pleased to announce the recipients for the 2009 Jay ... by Courage Center to people with disabilities who have achieved ... Award which acknowledges and honors a behind-the-scenes caregiver vital to ...
... FARMINGTON HILLS, Mich., Aug. 14 Work and economy related stress ... a new independent survey conducted by American Laser Centers, the largest ... of the respondents who took part in the survey (47 percent) ... stress. , , The physical toll ...
Cached Medicine News:Health News:Advocate Named One Of The Nation's Top 10 Health Systems 2Health News:Advocate Named One Of The Nation's Top 10 Health Systems 3Health News:Wine May Shield Breast Cancer Patients From Radiation Side Effects 2Health News:Americans United for Life Applauds Decision Protecting Women From Dangers of RU-486 2Health News:Kids of Deployed Soldiers Vulnerable to Stress 2Health News:Courage Center Names 2009 Phillips Award Recipients 2Health News:Courage Center Names 2009 Phillips Award Recipients 3Health News:Courage Center Names 2009 Phillips Award Recipients 4
... VH series, it is a ... independent C-arms and image intensifiers, ... for Cardiovascular and Angiography. There ... the examinations for cerebral, cardiac, ...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Rubidium Rb 82 Generator. ,The only generator-based Positron Emission Tomography agent reimbursed for the evaluation of coronary artery disease....
Kit for the Preparation of Technetium Tc 99m Teboroxime...
Medicine Products: